Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.India-based drug maker Aurobindo Pharma has received tentative approval from the FDA to manufacture and market Abacavir sulfate tablets, which are used in the treatment of HIV infection.
Subscribe to our email newsletter
The new drug application provides for the use of Abacavir sulfate 60mg tablets in combination with other antiretrovirals for use in pediatric patients for the treatment of HIV-1 infection.
The company had earlier received tentative approvals for Abacavir sulfate tablets 300mg and Abacavir sulfate oral solution 20mg/mL.